Lower plasma ApoA1 levels are found in Parkinson’s disease and associate with APOA1 genotype

BACKGROUND: The discovery of novel plasma-based biomarkers could lead to new approaches in the treatment of Parkinson’s disease (PD). Here we explore the role of plasma Apolipoprotein A1 (ApoA1) as a risk marker for PD and evaluate the influence of APOA1 promoter variation on plasma ApoA1 levels. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mov Disord
Main Authors: Swanson, Christine R., Li, Katherine, Unger, Travis L., Gallagher, Michael D., Van Deerlin, Vivianna M., Agarwal, Pinky, Leverenz, James, Roberts, John, Samii, Ali, Gross, Goldmann Rachel, Hurtig, Howard, Rick, Jacqueline, Weintraub, Daniel, Trojanowski, John Q., Zabetian, Cyrus, Chen-Plotkin, Alice S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362847/
https://ncbi.nlm.nih.gov/pubmed/25227208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados